Keith A A Fox Selected Research

Factor Xa (Coagulation Factor Xa)

10/2021	Termination Based on Event Accrual in Per Protocol Versus Intention to Treat in the ROCKET AF Trial.
1/2018	Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.
11/2017	Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
8/2017	Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
6/2017	Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF Trial.
1/2017	Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial).
1/2017	Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation: Results From ROCKET AF (Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
1/2017	Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis.
7/2016	On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
3/2016	Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith A A Fox Research Topics

Disease

130	Hemorrhage 12/2022 - 09/2002
123	Stroke (Strokes) 12/2022 - 10/2003
111	Acute Coronary Syndrome 08/2022 - 05/2002
102	Myocardial Infarction 12/2022 - 05/2002
83	Atrial Fibrillation 01/2022 - 01/2005
49	Embolism (Embolus) 01/2022 - 06/2008
40	ST Elevation Myocardial Infarction 04/2021 - 08/2002
34	Heart Failure 02/2021 - 09/2002
28	Peripheral Arterial Disease 12/2022 - 05/2007
25	Thrombosis (Thrombus) 01/2022 - 03/2005
25	Unstable Angina 01/2020 - 08/2002
24	Coronary Artery Disease (Coronary Atherosclerosis) 12/2022 - 02/2002
17	Vascular Diseases (Vascular Disease) 10/2022 - 06/2010
16	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2003
14	Ischemic Stroke 01/2022 - 05/2007
12	Ischemia 01/2019 - 07/2004
11	Non-ST Elevated Myocardial Infarction 04/2021 - 08/2002
10	Intracranial Hemorrhages (Intracranial Hemorrhage) 10/2021 - 04/2006
8	Atherosclerosis 01/2022 - 09/2009
8	Coronary Disease (Coronary Heart Disease) 01/2019 - 09/2004
7	Diabetes Mellitus 02/2021 - 02/2009
7	Inflammation (Inflammations) 04/2016 - 01/2003
6	Transient Ischemic Attack 05/2017 - 01/2005
5	Venous Thromboembolism 01/2022 - 06/2008
5	Hypertension (High Blood Pressure) 02/2021 - 01/2005
5	Body Weight (Weight, Body) 01/2021 - 04/2006
5	Stable Angina 08/2015 - 09/2004
4	Infarction (Infarctions) 01/2018 - 02/2005
3	Venous Thrombosis (Deep-Vein Thrombosis) 11/2018 - 03/2005
3	Carotid Artery Diseases 01/2018 - 01/2018
3	Chest Pain (Chest Pains) 11/2017 - 04/2010
3	Atherosclerotic Plaque (Atheroma) 02/2014 - 08/2003
3	Left Ventricular Dysfunction 07/2011 - 04/2005
3	Necrosis 03/2011 - 01/2004
2	Chronic Renal Insufficiency 08/2022 - 05/2009
2	Thromboembolism 02/2021 - 01/2020
2	Overweight 01/2021 - 01/2017
2	Death (Near-Death Experience) 01/2021 - 04/2013
2	Vascular System Injuries 01/2020 - 05/2002
2	Neoplasms (Cancer) 01/2019 - 01/2016

Drug/Important Bio-Agent (IBA)

90	RivaroxabanIBA 12/2022 - 06/2008
72	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2022 - 09/2002
57	Clopidogrel (Plavix)FDA Link 08/2022 - 09/2002
49	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 09/2011
44	Vitamin K FDA Link 10/2021 - 01/2013
34	Factor Xa (Coagulation Factor Xa)IBA 10/2021 - 03/2005
29	AnticoagulantsIBA 01/2022 - 04/2006
21	Prasugrel Hydrochloride FDA Link 08/2022 - 07/2010
16	CreatinineIBA 07/2020 - 11/2002
16	Heparin (Liquaemin)FDA LinkGeneric 01/2011 - 09/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 09/2010 - 02/2002
13	TroponinIBA 01/2022 - 02/2009
13	Fondaparinux (Arixtra)FDA Link 04/2021 - 03/2005
12	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2022 - 06/2010
11	Factor Xa InhibitorsIBA 01/2022 - 03/2005
10	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2004
10	Pharmaceutical PreparationsIBA 01/2019 - 02/2009
8	omega-Chloroacetophenone (Mace)IBA 10/2022 - 01/2018
8	Troponin IIBA 01/2021 - 03/2011
7	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 09/2002
7	Glycoproteins (Glycoprotein)IBA 01/2011 - 08/2002
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 04/2006
6	C-Reactive ProteinIBA 07/2017 - 01/2004
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015 - 06/2004
6	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2012 - 09/2002
6	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 03/2010 - 08/2003
5	AntithrombinsIBA 02/2021 - 09/2004
5	BradykininIBA 05/2013 - 09/2002
5	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2012 - 09/2002
4	Thrombin FDA Link 01/2020 - 03/2005
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2017 - 01/2003
4	vorapaxarIBA 01/2017 - 09/2009
4	Blood Glucose (Blood Sugar)IBA 10/2013 - 10/2005
4	ThienopyridinesIBA 03/2010 - 10/2005
3	apixabanIBA 01/2022 - 06/2009
3	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2017
3	Hemoglobins (Hemoglobin)IBA 07/2020 - 09/2010
3	pro-brain natriuretic peptide (1-76)IBA 10/2019 - 11/2016
3	Proton Pump InhibitorsIBA 01/2019 - 10/2015
3	LipidsIBA 01/2017 - 10/2005
3	Cytochrome P-450 CYP2C19IBA 03/2016 - 10/2010
3	Dalteparin (Dalteparin Sodium)FDA Link 02/2012 - 06/2010
3	Nifedipine (Adalat)FDA LinkGeneric 08/2007 - 09/2004
2	N(4)-oleylcytosine arabinosideIBA 02/2021 - 01/2018
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2019 - 01/2019
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 10/2007

Therapy/Procedure

107	Therapeutics 10/2022 - 05/2002
43	Percutaneous Coronary Intervention 08/2022 - 09/2002
11	Stents 03/2020 - 02/2004
9	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2020 - 01/2005
8	Surgical Amputation (Amputations) 01/2022 - 07/2010
8	Patient Readmission 11/2019 - 11/2005
7	Conservative Treatment 02/2012 - 07/2008
6	Secondary Prevention 01/2020 - 06/2008
5	Thrombolytic Therapy 11/2017 - 09/2002
3	Polypharmacy 11/2022 - 01/2016
3	Drug Therapy (Chemotherapy) 06/2021 - 02/2010
2	Length of Stay 01/2021 - 04/2003
2	Myocardial Revascularization 01/2020 - 08/2015